Search research articles
Contact Us
Filters
Showing results (311-320 of 343) with videos related to
Page
of 35
Sort By:
American Journal of Hypertension
|
April 27, 2012
Lysine-specific demethylase 1: an epigenetic regulator of salt-sensitive hypertension
Jonathan S Williams, Bindu Chamarthi, Mark O Goodarzi, et al.
High Blood Pressure & Cardiovascular Prevention : the Official Journal of the Italian Society of Hypertension
|
June 2, 2024
May Measure Month 2022 in Italy: A Focus on Fixed-dose Combination, Therapeutic Adherence, and Medical Inertia in a Nationwide Survey
Rita Del Pinto, Claudia Agabiti Rosei, Claudio Borghi, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
November 15, 2021
A multicenter study of skin toxicity management in patients with left-sided, RAS/BRAF wild-type metastatic colorectal cancer treated with first-line anti-EGFR-based doublet regimen: is there room for improvement?
Paolo Antonetti, Maria Concetta Fargnoli, Giampiero Porzio, et al.
Frontiers in Oncology
|
August 29, 2022
Primary versus secondary antiemetic prophylaxis with NK1 receptor antagonists in patients affected by gastrointestinal malignancies and treated with a doublet or triplet combination regimen including oxaliplatin and/or irinotecan plus fluoropyrimidines: A propensity score matched analysis
Alessandro Parisi, Riccardo Giampieri, Alex Mammarella, et al.
Frontiers in Oncology
|
November 15, 2021
Post-Induction Management in Patients With Left-Sided <i>RAS</i> and <i>BRAF</i> Wild-Type Metastatic Colorectal Cancer Treated With First-Line Anti-EGFR-Based Doublet Regimens: A Multicentre Study
Alessandro Parisi, Alessio Cortellini, Olga Venditti, et al.
International Journal of Cardiology. Hypertension
|
January 15, 2021
The 2020 Italian Society of Arterial Hypertension (SIIA) practical guidelines for the management of primary aldosteronism
Gian Paolo Rossi, Valeria Bisogni, Alessandra Violet Bacca, et al.
Journal of Hypertension
|
July 23, 2020
Serum uric acid, predicts heart failure in a large Italian cohort: search for a cut-off value the URic acid Right for heArt Health study
Maria L Muiesan, Massimo Salvetti, Agostino Virdis, et al.
Journal of Hypertension
|
October 24, 2019
Serum uric acid and fatal myocardial infarction: detection of prognostic cut-off values: The URRAH (Uric Acid Right for Heart Health) study
Edoardo Casiglia, Valérie Tikhonoff, Agostino Virdis, et al.
Journal of Nephrology
|
March 23, 2021
Association of uric acid with kidney function and albuminuria: the Uric Acid Right for heArt Health (URRAH) Project
Elisa Russo, Francesca Viazzi, Roberto Pontremoli, et al.
Journal of Human Hypertension
|
September 30, 2021
Identification of a plausible serum uric acid cut-off value as prognostic marker of stroke: the Uric Acid Right for Heart Health (URRAH) study
Valérie Tikhonoff, Edoardo Casiglia, Paolo Spinella, et al.
Page
of 35
Search research articles
Search
Showing results (311-320 of 343) with videos related to
Sort By:
Page
of 35
American Journal of Hypertension
|
April 27, 2012
Lysine-specific demethylase 1: an epigenetic regulator of salt-sensitive hypertension
Jonathan S Williams, Bindu Chamarthi, Mark O Goodarzi, et al.
High Blood Pressure & Cardiovascular Prevention : the Official Journal of the Italian Society of Hypertension
|
June 2, 2024
May Measure Month 2022 in Italy: A Focus on Fixed-dose Combination, Therapeutic Adherence, and Medical Inertia in a Nationwide Survey
Rita Del Pinto, Claudia Agabiti Rosei, Claudio Borghi, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
November 15, 2021
A multicenter study of skin toxicity management in patients with left-sided, RAS/BRAF wild-type metastatic colorectal cancer treated with first-line anti-EGFR-based doublet regimen: is there room for improvement?
Paolo Antonetti, Maria Concetta Fargnoli, Giampiero Porzio, et al.
Frontiers in Oncology
|
August 29, 2022
Primary versus secondary antiemetic prophylaxis with NK1 receptor antagonists in patients affected by gastrointestinal malignancies and treated with a doublet or triplet combination regimen including oxaliplatin and/or irinotecan plus fluoropyrimidines: A propensity score matched analysis
Alessandro Parisi, Riccardo Giampieri, Alex Mammarella, et al.
Frontiers in Oncology
|
November 15, 2021
Post-Induction Management in Patients With Left-Sided <i>RAS</i> and <i>BRAF</i> Wild-Type Metastatic Colorectal Cancer Treated With First-Line Anti-EGFR-Based Doublet Regimens: A Multicentre Study
Alessandro Parisi, Alessio Cortellini, Olga Venditti, et al.
International Journal of Cardiology. Hypertension
|
January 15, 2021
The 2020 Italian Society of Arterial Hypertension (SIIA) practical guidelines for the management of primary aldosteronism
Gian Paolo Rossi, Valeria Bisogni, Alessandra Violet Bacca, et al.
Journal of Hypertension
|
July 23, 2020
Serum uric acid, predicts heart failure in a large Italian cohort: search for a cut-off value the URic acid Right for heArt Health study
Maria L Muiesan, Massimo Salvetti, Agostino Virdis, et al.
Journal of Hypertension
|
October 24, 2019
Serum uric acid and fatal myocardial infarction: detection of prognostic cut-off values: The URRAH (Uric Acid Right for Heart Health) study
Edoardo Casiglia, Valérie Tikhonoff, Agostino Virdis, et al.
Journal of Nephrology
|
March 23, 2021
Association of uric acid with kidney function and albuminuria: the Uric Acid Right for heArt Health (URRAH) Project
Elisa Russo, Francesca Viazzi, Roberto Pontremoli, et al.
Journal of Human Hypertension
|
September 30, 2021
Identification of a plausible serum uric acid cut-off value as prognostic marker of stroke: the Uric Acid Right for Heart Health (URRAH) study
Valérie Tikhonoff, Edoardo Casiglia, Paolo Spinella, et al.
Page
of 35